A Post-Hoc Analysis of the Effect of Smoking Status on COPD Exacerbation Reductions with Budesonide/Glycopyrrolate/Formoterol Fumarate in Patients with COPD in the ETHOS Study

被引:0
作者
Bafadhel, M. [1 ]
Han, M. K. [2 ]
Singh, D. [3 ]
Jenkins, M. [4 ]
Dorinsky, P. [5 ]
Patel, M. [4 ]
机构
[1] Univ Oxford, Nuffield Dept Med, Resp Med Unit, Oxford, England
[2] Univ Michigan, Div Pulm & Crit Care Med, Ann Arbor, MI 48109 USA
[3] Univ Manchester, Manchester Univ NHS Fdn Trust, Med Evaluat Unit, Manchester, Lancs, England
[4] AstraZeneca, Cambridge, England
[5] AstraZeneca, Durham, NC USA
关键词
D O I
暂无
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
A1451
引用
收藏
页数:2
相关论文
共 50 条
  • [21] Benefits of Budesonide/Glycopyrronium/Formoterol Fumarate Dihydrate on COPD Exacerbations, Lung Function, Symptoms, and Quality of Life Across Blood Eosinophil Ranges: A Post-Hoc Analysis of Data from ETHOS
    Bafadhel, Mona
    Rabe, Klaus F.
    Martinez, Fernando J.
    Singh, Dave
    Darken, Patrick
    Jenkins, Martin
    Aurivillius, Magnus
    Patel, Mehul
    Dorinsky, Paul
    [J]. INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2022, 17 : 3061 - 3073
  • [22] Triple Therapy with Budesonide/Glycopyrronium/ Formoterol Fumarate Dihydrate versus Dual Therapies for Patients with COPD and Phenotypic Features of Asthma: A Pooled Post Hoc Analysis of KRONOS and ETHOS
    Muro, Shigeo
    Seki, Munehiro
    Hurst, John R.
    Petullo, David
    Marshall, Jonathan
    Bowen, Karin
    Darken, Patrick F.
    Duncan, Elizabeth A.
    Megally, Ayman
    Patel, Mehul
    [J]. INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2024, 19 : 2729 - 2737
  • [23] Improvements in lung function with budesonide/glycopyrrolate/formoterol fumarate metered dose inhaler versus dual therapies in patients with COPD: a sub-study of the ETHOS trial
    Rabe, Klaus F.
    Martinez, Fernando J.
    Singh, Dave
    Trivedi, Roopa
    Jenkins, Martin
    Darken, Patrick
    Aurivillius, Magnus
    Dorinsky, Paul
    [J]. THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE, 2021, 15
  • [24] Efficacy and Safety of Budesonide/Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler in Chinese Patients with COPD: A Subgroup Analysis of KRONOS
    Wang, Chen
    Yang, Ting
    Kang, Jian
    Chen, Rongchang
    Zhao, Li
    He, Huijie
    Assam, Pryseley N.
    Su, Rong
    Bourne, Eric
    Ballal, Shaila
    DeAngelis, Kiernan
    Dorinsky, Paul
    [J]. ADVANCES IN THERAPY, 2020, 37 (04) : 1591 - 1607
  • [25] The Effect of Maintenance Treatment with Erdosteine on Exacerbation Treatment and Health Status in Patients with COPD: A Post-Hoc Analysis of the RESTORE Dataset
    Calverley, Peter M. A.
    Papi, Alberto
    Page, Clive
    Rogliani, Paola
    Negro, Roberto W. Dal
    Cazzola, Mario
    Cicero, Arrigo F.
    Wedzicha, Jadwiga A.
    [J]. INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2022, 17 : 1909 - 1920
  • [26] Improvements in Lung Function with Budesonide/Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler (BGF MDI) Versus Dual Therapies in Patients with COPD: A Sub-Study of the ETHOS Trial
    Rabe, K. F.
    Martinez, F. J.
    Singh, D.
    McLaren, J.
    St Rose, E.
    Ballal, S.
    Darken, P.
    Aurivillius, M.
    Reisner, C.
    Dorinsky, P.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
  • [27] HEALTH CARE RESOURCE USE AND COSTS ASSOCIATED WITH PROMPT INITIATION OF BUDESONIDE/GLYCOPYRROLATE/FORMOTEROL FUMARATE AMONG PATIENTS WITH COPD: THE EROS STUDY
    Pollack, Michael
    Tkacz, Joseph
    Schinkel, Jill
    Lewing, Benjamin
    Agatep, Barnabie
    Swisher, Sean
    Patel, Sushma
    Edwards, Devechio
    Touchette, Daniel
    Portillo, Edward C.
    Feigler, Norbert
    Strange, Charlie
    [J]. CHEST, 2023, 164 (04) : 4969A - 4970A
  • [28] Effect of formoterol/budesonide combination on arterial blood gases in patients with acute exacerbation of COPD
    Cazzola, M
    Noschese, P
    De Michele, F
    D'Amato, G
    Matera, MG
    [J]. RESPIRATORY MEDICINE, 2006, 100 (02) : 212 - 217
  • [29] Benefits of Budesonide/Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler (BGF MDI) on Symptoms and Quality of Life in Patients with Chronic Obstructive Pulmonary Disease (COPD) in the ETHOS Trial
    Martinez, F. J.
    Rabe, K. F.
    Ferguson, G. T.
    Wedzicha, J. A.
    Trivedi, R.
    St Rose, E.
    Ballal, S.
    Darken, P.
    Aurivillius, M.
    Dorinsky, P.
    Reisner, C.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
  • [30] Pulmonary embolism diagnostic strategies in patients with COPD exacerbation: post-hoc analysis of the PEP trial
    Mai, Vicky
    Rambaud, Geoffroy
    Motreff, Camille
    Sanchez, Olivier
    Roy, Pierre-Marie
    Auffret, Yannick
    Le Mao, Raphael
    Gagnadoux, Frederic
    Paleiron, Nicolas
    Schmidt, Jeannot
    Pastre, Jean
    Nonent, Michel
    Tromeur, Cecile
    Salaun, Pierre-Yves
    Mismetti, Patrick
    Girard, Philippe
    Lacut, Karine
    Lemarie, Catherine
    Meyer, Guy
    Leroyer, Christophe
    Le Gal, Gregoire
    Bertoletti, Laurent
    Couturaud, Francis
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2023, 62